Page 69 - Traité de chimie thérapeutique 6 Médicaments antitumoraux

1. CIBLES DES AGENTS ANTTTUMORAUX 25

HYPOXIE, MÉTASTASES, ANGIOGENÈSE
CAIRNS R.A. et al., Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT
murine tumors, Cancer Res., 2001, 61, 8903-8908.
CAVALLARO U., CHRISTOFORI G., Cell adhesion in tumor invasion and metastasis:
loss of the glue is not enough, Biochim. Biophys. Acta, 2001, 1552, 39-45.
DENKO N.C., GIACCIA A.J., Tumor hypoxia, the physiological link between Trousseau's
syndrome (carcinoma-induced coagulopathy) and metastasis, CancerRes., 2001, 61,
795-798.
SPERL S. et al., The uPA/uPA Receptor system as a target for tumortherapy, Drug News
Perspect., 2001, 14, 401.
CAVALLARO U. et al., Cadherins and the tumour progression: is it all in a switch ? Can-
cer Lett., 2002, 176, 123-128.
GRIFFITHS J.R. et al., Metabolic changes detected by magnetic resonance studies of
HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1[3
(HIF-1B) : evidence of an anabolic role for the HIF-1 pathway, CancerRes., 2002, 62,
688-695.
LEEK R.D. et al., Relation of hypoxia-inducible Factor-2a (HIF-2a) expression in tumor-
infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phospho-
rylase pathway in human breast cancer, Cancer Res., 2002, 62, 1326-1329.
ROFSTAD E.K. et al., Hypoxia promotes lymph node metastasis in human melanoma
xenografts by up-regulating the urokinase-type plasminogen activator receptor, Can-
cer Res., 2002, 62, 1847-1853.
SEMENZA G.L., HIF-1 and tumor progression: pathophysiology and therapeutics,
Trends Mol. Med., 2002, 8, S62-S67.
SIGNALISATION CELLULAIRE
MAKIN G., HICKMAN J.A., Apoptosis and cancerchemotherapy, Cel. Tissue Res., 2000,
301, 143-152.
NYLANDSTED J. et al., Heat shock protein 70 is required forthe survival of cancer cells,
Ann. N. Y. Acad. Sci., 2000, 926, 122-125.
WEBSTER C.I., COOPER M.A., Kinetic analysis of high-mobility-group proteins HMG-1
and HMG-I/Y binding to cholesterol-tagged DNA on a supported lipid monolayer,
Nucleic Acids Res., 2000, 28, 1618-1624.
YOSHIDA B.A. et al., Metastasis-suppressor genes : a review and perspective on an
emerging field, J. Nat/. Cancer lnst., 2000, 92, 1717-1730.
ALTUCCI L., GRONEMEYER H., Nuclear receptors in cell lite and death, Trends Endo-
crinol. Metab., 2001, 12, 460-468.
ANDRIEU-ABADIE N. et al., Ceramide in apoptosis signaling : relationship with oxidative
stress, Free Rad. Bio/. Med., 2001, 31, 717-728.
BRAZIL D.P., HEMMINGS B.A., Ten years of protein kinase B signalling: a hard Akt to
follow, Trends Biochem. Sci., 2001, 26, 657-664.
Mc MAHON M., WOODS D., Regulation of the p53 pathway by Ras, the plot thickens,
Biochim. Biophys. Acta - Rev. Cancer, 2001, 1471, M63-M71.
DANNENBERG A.J. et al., Cyclooxygenase 2 : a pharmacological target for the preven-
tion of cancer, Lancet Oncol., 2001, 2, 544-551.